Document is current
Any future updates will be listed below
-
Authors
Mashouf, Parham
Tabibzadeh, Nahid
Kuraoka, Shohei
Oishi, Haruka
Morizane, Ryuji https://orcid.org/0000-0002-0377-5667
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK133821, DK127587, DK126023)
- License Information
-
More Information
Article History
Received: 14 March 2024
Revised: 21 June 2024
Accepted: 5 July 2024
First Online: 18 July 2024
Declarations
:
: The human cell lines used in this study were de-identified and exempt from IRB approval. The use of human cell lines were reviewed and approved by the Mass General Brigham Institutional Biosafety Committee.
: All authors consented to publish the manuscript.
: R.M. is an inventor on a patent related to this work filed by the President and Fellows of Harvard College and Mass General Brigham (PCT/US2018/036677). R.M. holds a stock option in Trestle Biotherapeutics. The authors declare no other competing interests.
